StockData
Cryo-Cell International Inc logo

Cryo-Cell International Inc (CCEL) stock

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 2/30
$4.85−0.55 (-10.19%)

Close on Nov 13, 2026Market cap $39.10MP/E –Yield –

Cryo-Cell International gross margin

Gross margin is gross profit as a percentage of revenue.

Cryo-Cell International's gross margin for the twelve months ending Aug 31, 2026 was 78.5%. For fiscal 2025 it was 76.6%, against 75.2% the year before. The highest annual figure on record is 76.6% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Nov 30, 202576.6%+1.5
FY2024Nov 30, 202475.2%+1.9
FY2023Nov 30, 202373.2%+2.2
FY2022Nov 30, 202271.0%+2.1
FY2021Nov 30, 202168.9%−0.1
FY2020Nov 30, 202069.0%+0.5
FY2019Nov 30, 201968.5%−2.3
FY2018Nov 30, 201870.8%−2.7
FY2017Nov 30, 201773.5%−1.5
FY2016Nov 30, 201675.0%+1.7
FY2015Nov 30, 201573.3%+1.3
FY2014Nov 30, 201472.0%+0.0
FY2013Nov 30, 201372.0%−0.8
FY2012Nov 30, 201272.8%−2.7
FY2011Nov 30, 201175.4%+0.8
FY2010Nov 30, 201074.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ3 2026Aug 31, 202679.4%+2.4
Q2 FY2026CQ2 2026May 31, 202678.4%+1.9
Q1 FY2026CQ1 2026Feb 28, 202678.4%+3.3
Q4 FY2025CQ4 2025Nov 30, 202577.9%−1.7
Q3 FY2025CQ3 2025Aug 31, 202577.0%+3.3
Q2 FY2025CQ2 2025May 31, 202576.6%+1.8
Q1 FY2025CQ1 2025Feb 28, 202575.1%+1.4
Q4 FY2024CQ4 2024Nov 30, 202479.6%+5.3
Q3 FY2024CQ3 2024Aug 31, 202473.6%+1.0
Q2 FY2024CQ2 2024May 31, 202474.8%+2.4
Q1 FY2024CQ1 2024Feb 29, 202473.7%+0.1
Q4 FY2023CQ4 2023Nov 30, 202374.3%+1.9
Q3 FY2023CQ3 2023Aug 31, 202372.6%+3.2
Q2 FY2023CQ2 2023May 31, 202372.4%+1.3
Q1 FY2023CQ1 2023Feb 28, 202373.6%+2.6
Q4 FY2022CQ4 2022Nov 30, 202272.5%+3.8
Q3 FY2022CQ3 2022Aug 31, 202269.4%+2.2
Q2 FY2022CQ2 2022May 31, 202271.2%+2.0
Q1 FY2022CQ1 2022Feb 28, 202271.0%+0.4
Q4 FY2021CQ4 2021Nov 30, 202168.6%−0.7
Q3 FY2021CQ3 2021Aug 31, 202167.2%−3.7
Q2 FY2021CQ2 2021May 31, 202169.2%+0.7
Q1 FY2021CQ1 2021Feb 28, 202170.7%+3.5
Q4 FY2020CQ4 2020Nov 30, 202069.3%−1.2
Q3 FY2020CQ3 2020Aug 31, 202070.9%+2.4
Q2 FY2020CQ2 2020May 31, 202068.5%+0.8
Q1 FY2020CQ1 2020Feb 29, 202067.2%+0.1
Q4 FY2019CQ4 2019Nov 30, 201970.5%+1.6
Q3 FY2019CQ3 2019Aug 31, 201968.5%+0.1
Q2 FY2019CQ2 2019May 31, 201967.7%−5.1
Q1 FY2019CQ1 2019Feb 28, 201967.1%−7.2
Q4 FY2018CQ4 2018Nov 30, 201868.9%−5.8
Q3 FY2018CQ3 2018Aug 31, 201868.4%−2.9
Q2 FY2018CQ2 2018May 31, 201872.8%−1.7
Q1 FY2018CQ1 2018Feb 28, 201874.3%+0.5
Q4 FY2017CQ4 2017Nov 30, 201774.7%−0.7
Q3 FY2017CQ3 2017Aug 31, 201771.3%–
Q2 FY2017CQ2 2017May 31, 201774.5%–
Q1 FY2017CQ1 2017Feb 28, 201773.8%–
Q4 FY2016CQ4 2016Nov 30, 201675.4%–

More Cryo-Cell International figures

See a number that looks wrong?